N/A
N=10
Usability of the MeTime MS App
Multiple Sclerosis · Pain · Fatigue Symptom
Bottom Line
View on ClinicalTrials.gov: NCT07123272 ↗Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Nov 2025
Primary outcome: Primary: Participant Perception of Me Time MS App Usability — 37; 11; 9; 4 Comments
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Self-guided smartphone application for relaxing acupressure (Behavioral); Self-guided smartphone application for stimulating acupressure (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Michigan
- Primary completion
- May 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Participant Perception of Me Time MS App Usability |
37; 11; 9; 4; 13; 6 | — |
| SECONDARY System Usability Scale (SUS) Adapted for the MeTime MS App |
35.8; 29.5 | — |
Summary
The Me Time MS Application was designed to enable self-administration of acupressure. Two forms of acupressure - either "relaxing" or "stimulating" protocols - are administered through the Me Time MS app.
The goal of this study is to assess the usability of the Me Time MS app in a sample of 10 adults with multiple sclerosis (MS).
Eligibility Criteria
Inclusion Criteria
- MS diagnosis (all MS subtypes included)
- Age 18 years or older
- Average Fatigue Severity Scale (FSS) score ≥ 4 at screening coupled with the opinion of the volunteer that the fatigue has interfered with their daily activities for ≥ 3 months
- Presence of chronic pain defined as moderate to severe pain for ≥ 3-month duration that is ≥ 4 on average using a 0-10 numerical rating scale
- Home access to internet via Wi-Fi or cellular data
- Active email account
Exclusion Criteria
- Not fluent in English
- Pregnancy or breast feeding, or anticipate pregnancy in next 6 months
- Inability to use smartphone/tablet and/or MeTime MS mobile app
- Anything at the discretion of the PI or study team that would preclude participation in the study
Data sourced from ClinicalTrials.gov (NCT07123272). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.